These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 8460241)

  • 21. From left ventricular hypertrophy to congestive heart failure: management of hypertensive heart disease.
    Gradman AH; Alfayoumi F
    Prog Cardiovasc Dis; 2006; 48(5):326-41. PubMed ID: 16627048
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Hypertension and the heart.
    Mancia G; Scopelliti F; Grassi G
    Semin Cardiothorac Vasc Anesth; 2006 Sep; 10(3):198-202. PubMed ID: 16959750
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The transition from hypertrophy to failure: how certain are we?
    Drazner MH
    Circulation; 2005 Aug; 112(7):936-8. PubMed ID: 16103249
    [No Abstract]   [Full Text] [Related]  

  • 24. Hypertensive heart disease.
    Diamond JA; Phillips RA
    Hypertens Res; 2005 Mar; 28(3):191-202. PubMed ID: 16097361
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Nicorandil but not ISDN upregulates endothelial nitric oxide synthase expression, preventing left ventricular remodeling and degradation of cardiac function in Dahl salt-sensitive hypertensive rats with congestive heart failure.
    Horinaka S; Kobayashi N; Yagi H; Mori Y; Matsuoka H
    J Cardiovasc Pharmacol; 2006 May; 47(5):629-35. PubMed ID: 16775500
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [How to choose and adequate antihypertensive drug depending on the type of the existing heart damage?].
    Alegría Ezquerra E; Martínez Monzonís A; Grau Sepúlveda A
    Rev Esp Cardiol; 1997; 50 Suppl 4():57-60. PubMed ID: 9411589
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Influence of the type and degree of left ventricular hypertrophy on the prevalence of ventricular arrhythmias in patients with hypertensive heart disease.
    Kunisek J; Zaputović L; Mavrić Z; Kunisek L; Bruketa-Markić I; Karlavaris R; Lukin-Eskinja K
    Med Klin (Munich); 2008 Oct; 103(10):705-11. PubMed ID: 18936895
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Diastolic dysfunction as a link between hypertension and heart failure.
    Verma A; Solomon SD
    Med Clin North Am; 2009 May; 93(3):647-64. PubMed ID: 19427497
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Impact of arterial hypertension on the heart].
    Herpin D
    Rev Prat; 1999 Mar; 49(5):491-4. PubMed ID: 10358398
    [TBL] [Abstract][Full Text] [Related]  

  • 30. K(ATP) activation prevents progression of cardiac hypertrophy to failure induced by pressure overload via protecting endothelial function.
    Gao S; Long CL; Wang RH; Wang H
    Cardiovasc Res; 2009 Aug; 83(3):444-56. PubMed ID: 19304734
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Left ventricular hypertrophy and heart failure in women.
    Agabiti-Rosei E; Muiesan ML
    J Hypertens Suppl; 2002 May; 20(2):S34-8. PubMed ID: 12183849
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Left atrial systolic force in hypertensive patients with left ventricular hypertrophy: the LIFE study.
    Chinali M; de Simone G; Wachtell K; Gerdts E; Gardin JM; Boman K; Nieminen MS; Papademetriou V; Dahlöf B; Devereux RB
    J Hypertens; 2008 Jul; 26(7):1472-6. PubMed ID: 18551025
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Matrix metalloproteinases/tissue inhibitors of metalloproteinases: relationship between changes in proteolytic determinants of matrix composition and structural, functional, and clinical manifestations of hypertensive heart disease.
    Ahmed SH; Clark LL; Pennington WR; Webb CS; Bonnema DD; Leonardi AH; McClure CD; Spinale FG; Zile MR
    Circulation; 2006 May; 113(17):2089-96. PubMed ID: 16636176
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Myocardial Remodeling in Hypertension.
    González A; Ravassa S; López B; Moreno MU; Beaumont J; San José G; Querejeta R; Bayés-Genís A; Díez J
    Hypertension; 2018 Sep; 72(3):549-558. PubMed ID: 30354762
    [No Abstract]   [Full Text] [Related]  

  • 35. A new porcine model of hypertensive cardiomyopathy: a helpful tool to explore the HFpEF mystique.
    Hu K; Ertl G
    Am J Physiol Heart Circ Physiol; 2015 Nov; 309(9):H1390-1. PubMed ID: 26386114
    [No Abstract]   [Full Text] [Related]  

  • 36. Symptoms and tests of ventricular performance in the evaluation of chronic heart failure.
    Jafri SM; Lakier JB; Rosman HS; Peterson E; Goldstein S
    Am Heart J; 1986 Jul; 112(1):194-6. PubMed ID: 3728283
    [No Abstract]   [Full Text] [Related]  

  • 37. [Physiopathology and clinical classification of left ventricular dysfunction].
    Giordano A
    G Ital Cardiol; 1991 Aug; 21(8):899-904. PubMed ID: 1769461
    [No Abstract]   [Full Text] [Related]  

  • 38. [Symptoms of left ventricular insufficiency. Physiopathologic interpretation].
    Castaigne A; Ettner A; Palsky E
    Rev Prat; 1982 Feb; 32(7):509-17. PubMed ID: 6461915
    [No Abstract]   [Full Text] [Related]  

  • 39. [Grading of clinical findings and classification in cardiology].
    Theisen K
    Internist (Berl); 1992 Aug; 33(8):521-6. PubMed ID: 1526715
    [No Abstract]   [Full Text] [Related]  

  • 40. [Relationship between the afterload electrocardiographic picture and dynamics of the left ventricle in hypertensive cardiopathy].
    Fiorentini C; Moruzzi P; Olivari MT; Sganzerla P; Ging LQ; Guazzi M
    Cardiologia; 1982; 27(1):47-9. PubMed ID: 6927445
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.